Hee Yeon Kim
Breast surgery division (Breast center)
Specialty
Breast disease, general surgery department
Treatment hours
| Mon | Tue | Wed | Thu | Fri | Sat |
|---|
- 바로가기 메뉴
- 본문 바로가기
- 주메뉴 바로가기
Dec
-
- Date
- 2(Mon)
- 3(Tue)
- 1(Wed)
- 2(Thu)
- 3(Fri)
- 4(Fri)
-
- AM
-
- PM
-
- Date
- 6(Mon)
- 7(Tue)
- 8(Wed)
- 9(Thu)
- 10(Fri)
- 11(Fri)
-
- AM
-
Ambulatory
-
- PM
-
Ambulatory
-
- Date
- 13(Mon)
- 14(Tue)
- 15(Wed)
- 16(Thu)
- 17(Fri)
- 18(Sat)
-
- AM
-
Ambulatory
-
Ambulatory
-
- PM
-
Ambulatory
-
Ambulatory
-
- Date
- 20(Mon)
- 21(Tue)
- 22(Wed)
- 23(Thu)
- 24(Fri)
- 25(Sat)
-
- AM
-
Ambulatory
-
- PM
-
Ambulatory
-
- Date
- 27(Mon)
- 28(Tue)
- 29(Wed)
- 30(Thu)
- 31(Fri)
- 1(Sat)
-
- AM
-
Ambulatory
-
Ambulatory
-
- PM
-
Ambulatory
-
Ambulatory
- Education/Career/Main Activities
- Research/Publication
- Press Board
Education
Ulsan Science High School graduation
M.D. degree
College of Medicine, Inje University
Master's degree
Department of Medicine, Graduate School, Inje University
Thesis: Plasma and urinary endogenous metabolites as possible surrogate biomarkers for breast cancer screening: Preliminary study
Career
Ulsan Science High School graduation
M.D. degree
College of Medicine, Inje University
Master's degree
Department of Medicine, Graduate School, Inje University
Thesis: Plasma and urinary endogenous metabolites as possible surrogate biomarkers for breast cancer screening: Preliminary study
Main Activities
Research/Publication
1. Lee A, Kim HY, Kim TH, Ahn KJ, Cho H, Park SK, Choi Y. Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis. J Korean Med Sci. 2022 Feb;37(8):e64. (First-author)
2. Jin Hee Park, Hee Yeon Kim, Anbok Lee, Young Kyeong Seo, Il-Hwan Kim, Eun-tae Park, Mi Seon Kang, Sung Jae Park, SaeGwang Park, Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1, International Journal of Radiation Oncology*Biology*Physics, Volume 110, Issue 2,2021,Pages 510-520,ISSN 0360-3016, (First-author)
3. Kim HY, Kim TH, Yoon HK, Lee A. The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer. J Breast Cancer. 2019 Sep;22(3):425-438. (First-author)
4.Kim, H.Y., Choi, JH., Haque, M.M. et al. Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge. Cancer Immunol Immunother 71, 967?978 (2022). (First-author)
5.Nguyen Phuoc Long, Dayoung Heo, Hee-Yeon Kim, Tae Hyun Kim, Jae-Gook Shin, Anbok Lee, Dong-Hyun Kim,
Metabolomics-guided global pathway analysis reveals better insights into the metabolic alterations of breast cancer, Journal of Pharmaceutical and Biomedical Analysis, Volume 202,2021,114134,
ISSN 0731-7085, (Co-author)
6.Lee A, Jin H, Masudul Haque M, Kim HY, Jung H, Park JH, Kim I, Song JY, Yoon HK, Kim HK, Kim HK, et al: Synergism of a novel MCL-1 downregulator, acriflavine, with navitoclax (ABT?263) in triple?negative breast cancer, lung adenocarcinoma and glioblastoma multiforme. Int J Oncol 60: 2, 2022 (co-author)
7.Quan X, Lee J-, Park JH, Haque M., Kim HY, Kim I, et al. Induction of Triple-negative Breast Cancer Cells to Immunogenic Cell Death and Increase Cross-Presentation by Streptomyces sanyensis. Pharmacognosy Research. 2021;13(3):165-172. (co-author)